Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study

Xiaoyan A Qu1, Johannes M Freudenberg1, Philippe Sanseau2

  • 1Computational Biology, Quantitative Sciences, GlaxoSmithKline R&D, RTP, NC, USA.

Drug Discovery Today
|March 26, 2014
PubMed
Summary

This study introduces a new framework using transcriptomics data to find novel therapeutic targets and repurpose drugs for psoriasis, a chronic inflammatory skin disease. This approach aims to accelerate the development of effective psoriasis treatments.